Nonprescription drug preparations manufacturing · New York

LNK - 145 Ricefield

Hauppauge, NY · ~180 workers · 8 years of OSHA Injury Tracking Application data.

C
Average Safety Record
2.8
Avg TCR
3.3
Industry avg
0
Fatalities
Subscribe to safety-record updates (RSS)

The verdict

LNK - 145 Ricefield runs at 85% of its industry's injury rate - about level with the typical Nonprescription drug preparations manufacturing workplace, earning a grade C.

LNK - 145 Ricefield: 2.8 TCR = 85% of Nonprescription drug preparations manufacturing BLS 3.3 · 8y Form 300A (see methodology below)

LNK - 145 Ricefield safety composite

LNK - 145 Ricefield scores strongest on fatalities (safer than 50% of same-industry peers) and weakest on total case rate (tcr) (safer than 29%), blended into one 0-100 breakdown against same-industry peers. A missing measure drops out and redistributes its weight rather than deflating the score. This is a per-dimension breakdown, distinct from the single letter grade above it (which weights TCR alone against the BLS industry benchmark).

D

39/100

Percentile-weighted across 3 of 3 measures

Total Case Rate (TCR)
F 2.82 per 100 workers

Safer than 29% of industry peers

DART rate
D 0.96 per 100 workers

Safer than 43% of industry peers

Fatalities
D 0

Safer than 50% of industry peers

Benchmarked live against every credibly-rated employer in the same NAICS industry code in the current OSHA extract (a segment must have at least 8 rated peers to benchmark). Not a legal or compliance determination; PlainSafetyScore's own weighting (TCR 40%, DART 35%, fatalities 25%).

TCR Δ

−1.0

2016→2023

LNK - 145 Ricefield injury rate improved

LNK - 145 Ricefield's TCR fell 1.0 from 1.9 in 2016 to 1.0 in 2023. Peak filing year was 2017 at 8.6 TCR. In 2023, DART was 0.34× this establishment's average TCR (severity share of cases).

2016=1.9 · 2017=8.6 · 2018=2.5 · 2019=2.2 · 2020=1.3 · 2021=3.2 · 2022=1.8 · 2023=1.0

OSHA ITA Form 300A scorecard

Establishment book 325412 · Hauppauge, NY AT/BELOW-IND · MID

Grade C · TCR 2.8 · 85% of ind

  • DART 1.0 DART
  • RANK #36/64
  • PHOTO Humco - Texarkana
  • BOOK 8y book
  • INJ 35 inj
  • SIZE ~180 FTE

Nearest TCR peer: Humco - Texarkana (0.0 TCR gap)

Read with this employer → · Industry book → · New York employers → · Look up another →

LNK - 145 Ricefield in the TCR neighbourhood

Average Total Case Rate among this establishment and nearest same-industry peers

TCR

What this shows LNK - 145 Ricefield averages 2.8 TCR (85% of the Nonprescription drug preparations manufacturing BLS benchmark).

Source U.S. Department of Labor, OSHA Injury Tracking Application (Form 300A) As of 2026-08-25

LNK - 145 Ricefield TCR series: 2016=1.9 · 2017=8.6 · 2018=2.5 · 2019=2.2 · 2020=1.3 · 2021=3.2 · 2022=1.8 · 2023=1 · BLS 3.3

Where LNK - 145 Ricefield falls in its industry

855 Nonprescription drug preparati establishments

Safer than 29% of graded establishments in this industry, whose median TCR is 1.6.

More dangerous than peersSafer than peers

Narrower to New York alone (the establishments it most directly competes with for workers and contracts): ranked #36 safest of 64 Nonprescription drug preparati employers in New York.

LNK - 145 Ricefield (180 employees, TCR 2.8) among 29 same-industry peers, split at the industry median of 171 employees and a TCR of 1.6 2×2 strategic matrix plotting 30 entities by Average employees (X) and Total Case Rate (Y), with a crosshair dividing the plot into four quadrants. Larger & higher-riskSmaller & higher-riskLarger & saferSmaller & safer than peers 01,0002,0003,0004,000 051015 Average employees Total Case Rate LNK - 145 Ricefield
LNK - 145 Ricefield (180 employees, TCR 2.8) among 29 same-industry peers, split at the industry median of 171 employees and a TCR of 1.6

LNK - 145 Ricefield has more employees than the Nonprescription drug preparations manufa median and a higher injury rate than the industry's median TCR of 1.6. Workforce size and injury rate do not always move together within the same industry -- some of its smaller peers run higher rates than its larger ones, and vice versa.

Year-by-Year Safety Data

Year TCR DART Injuries Illnesses Fatalities
2023 1.0 1.0 2 0 0
2022 1.8 1.8 4 0 0
2021 3.2 3.2 7 0 0
2020 1.3 1.3 1 2 0
2019 2.2 1.8 3 2 0
2018 2.5 1.9 3 1 0
2017 8.6 8.0 13 1 0
2016 1.9 1.3 2 1 0

OSHA ITA peer cross-reference

Establishment peer ledger

325412 · NY · Hauppauge

855 Nonprescription drug preparations manufacturing employers nationwide with a credible TCR · 21,008 rated employers in New York with headcount on file · 154 employers in Hauppauge, NY · 4 cross-state NAT-TCR peers · 4 cross-state NAT-SIZE peers. Closest matches by relationship code are listed below.

Rel Establishment Metric
NAICS-TCR Humco - Texarkana 2.8 TCR
NAICS-TCR Xttrium Laboratories Inc. 2.8 TCR
NAICS-TCR ONY Biotech 2.8 TCR
NAICS-TCR Building 2033 2.8 TCR
STATE-SIZE Construction - Paving 180 FTE
STATE-SIZE PS Marcato Elevator Co., Inc. 180 FTE
STATE-SIZE Century Direct LLC 180 FTE
STATE-SIZE BASF Colors & Effects - Peekskill 180 FTE
CITY-NEAR Advance Care Alliance of NY HQ Hauppauge 990 FTE
CITY-NEAR Teachers Federal Credit Union 786 FTE
CITY-NEAR RECONN 9009 781 FTE
CITY-NEAR CONTRACT PHARMACAL CORP 691 FTE
NAT-TCR S & S Dairy 2.8 TCR
NAT-TCR Complete Care Green Knoll 2.8 TCR
NAT-TCR CYE Kewanee 2.8 TCR
NAT-TCR Sidney EMS - Ohio 2.8 TCR
NAT-SIZE Gervais School District 180 FTE
NAT-SIZE Heather Hill Care Communities 180 FTE
NAT-SIZE Mayo Clinic Health System-Sparta 180 FTE
NAT-SIZE SC Steel LLC 180 FTE

Rel codes: NAICS-TCR · STATE-SIZE · CITY-NEAR · NAT-TCR/NAT-SIZE cross-state. Read with this employer →

Data Source: OSHA Injury Tracking Application (ITA), mandatory establishment-level injury/illness reports. Grades compare employer Total Case Rate (TCR) to BLS IIF industry benchmarks. Data covers years reported by this establishment: 2023, 2022, 2021, 2020, 2019, 2018, 2017, 2016. This is publicly available government data - not a legal determination of workplace conditions.
Data sourced from official public datasets. See our methodology for details.